Molecular and cellular dissection of NMDA receptor subtypes as antidepressant targets

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neuroscience and Biobehavioral Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neubiorev.2017.08.012PMID 28843752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)

  2017cited by this paper
• Current and Future Perspectives on the Major Depressive Disorder: Focus on the New Multimodal Antidepressant Vortioxetine.

  2017cited by this paper
• Loss of GluN2D subunit results in social recognition deficit, social stress, 5‐HT2C receptor dysfunction, and anhedonia in mice

  2017influential reference
• Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies.

  2017cited by this paper
• The Role of GluN2C-Containing NMDA Receptors in Ketamine's Psychotogenic Action and in Schizophrenia Models

  2016cited by this paper
• GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice.

  2016cited by this paper
• GluN2B-Containg NMDA Receptors on Adult-Born Granule Cells Contribute to the Antidepressant Action of Fluoxetine

  2016cited by this paper
• Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains

  2016cited by this paper
• Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.

  2016influential reference
• Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.

  2016influential reference
• NR2A-Containing NMDARs in the Prefrontal Cortex Are Required for Working Memory and Associated with Age-Related Cognitive Decline

  2016cited by this paper
• NMDAR inhibition-independent antidepressant actions of ketamine metabolites

  2016cited by this paper
• The NMDA receptor GluN2C subunit controls cortical excitatory-inhibitory balance, neuronal oscillations and cognitive function

  2016cited by this paper
• GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia

  2016cited by this paper
• Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures.

  2016cited by this paper
• New neurons in the adult striatum: from rodents to humans.

  2015cited by this paper
• NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism.

  2015influential reference
• A structural biology perspective on NMDA receptor pharmacology and function.

  2015cited by this paper
• Conditional loss of GluN2B in cortex and hippocampus impairs attentional set formation.

  2015cited by this paper
• Increased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a.

  2015cited by this paper
• Evidence for glycinergic GluN1/GluN3 NMDA receptors in hippocampal metaplasticity.

  2015cited by this paper
• GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine

  2014influential reference
• Potentiation of GluN2C/D NMDA Receptor Subtypes in the Amygdala Facilitates the Retention of Fear and Extinction Learning in Mice

  2014cited by this paper
• Phenotype of mice with inducible ablation of GluA1 AMPA receptors during late adolescence: Relevance for mental disorders

  2014cited by this paper
• Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade

  2014influential reference
• Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses

  2014cited by this paper
• Impact of adolescent GluA1 AMPA receptor ablation in forebrain excitatory neurons on behavioural correlates of mood disorders

  2014cited by this paper
• Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

  2014cited by this paper
• Neurogenesis in the striatum of the adult human brain.

  2014cited by this paper
• The Role of GluN2A and GluN2B Subunits on the Effects of NMDA Receptor Antagonists in Modeling Schizophrenia and Treating Refractory Depression

  2014influential reference
• Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists

  2014cited by this paper
• Structure, function, and pharmacology of NMDA receptor channels.

  2014cited by this paper
• Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.

  2014influential reference
• GluN2B-Containing NMDA Receptors Promote Glutamate Synapse Development in Hippocampal Interneurons

  2014cited by this paper
• Loss of GluN2A‐containing NMDA receptors impairs extra‐dimensional set‐shifting

  2014cited by this paper
• Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.

  2013cited by this paper
• The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.

  2013cited by this paper
• Significant increase in anxiety during aging in mGlu5 receptor knockout mice.

  2013influential reference
• Involvement of the N-methyl-d-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity

  2013cited by this paper
• Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects.

  2013cited by this paper
• Dichotomy in the anxiolytic versus antidepressant effect of C-terminal truncation of the GluN2A subunit of NMDA receptors.

  2013influential reference
• Knockdown of BNST GluN2B-containing NMDA receptors mimics the actions of ketamine on novelty-induced hypophagia

  2013cited by this paper
• Learned helplessness: unique features and translational value of a cognitive depression model

  2013cited by this paper
• Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain.

  2013cited by this paper
• A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder

  2012cited by this paper
• Evolution of GluN2A/B cytoplasmic domains diversified vertebrate synaptic plasticity and behavior

  2012influential reference
• Synaptic Dysfunction in Depression: Potential Therapeutic Targets

  2012cited by this paper
• NR2C in the Thalamic Reticular Nucleus; Effects of the NR2C Knockout

  2012cited by this paper
• Synaptic mechanisms underlying rapid antidepressant action of ketamine.

  2012cited by this paper
• Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations.

  2012cited by this paper
• Combined subunit‐specific and unspecific inhibition of NMDA receptors triggers distinct cortical c‐fos expression patterns

  2012cited by this paper
• GluN2B-Containing NMDA Receptors Promote Wiring of Adult-Born Neurons into Olfactory Bulb Circuits

  2012cited by this paper
• Genetic, pharmacological and lesion analyses reveal a selective role for corticohippocampal GLUN2B in a novel repeated swim stress paradigm.

  2011cited by this paper
• A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory

  2011cited by this paper
• New advances in NMDA receptor pharmacology.

  2011cited by this paper
• A critical role for GluN2B-containing NMDA receptors in cortical development and function.

  2011influential reference
• Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory.

  2011cited by this paper
• Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.

  2011influential reference
• A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia

  2011cited by this paper
• Essential Role of NMDA Receptor Channel ε4 Subunit (GluN2D) in the Effects of Phencyclidine, but Not Methamphetamine

  2010cited by this paper
• mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

  2010influential reference
• Bupropion for Depression in Schizophrenia

  2010cited by this paper
• Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

  2010cited by this paper
• Structural Determinants of d-Cycloserine Efficacy at the NR1/NR2C NMDA Receptors

  2010influential reference
• Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

  2010influential reference
• Beyond the monoaminergic hypothesis: Agomelatine, a new antidepressant with an innovative mechanism of action

  2009cited by this paper
• Reduced spatial learning in mice treated with NVP-AAM077 through down-regulating neurogenesis.

  2009cited by this paper
• Involvement of NMDAR2A tyrosine phosphorylation in depression‐related behaviour

  2009cited by this paper
• Differential c-Fos induction by different NMDA receptor antagonists with antidepressant efficacy: potential clinical implications.

  2009cited by this paper
• Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine

  2009influential reference
• Negative regulation of neurogenesis and spatial memory by NR2B‐containing NMDA receptors

  2008cited by this paper
• AMPA receptor subunit 1 (GluR‐A) knockout mice model the glutamate hypothesis of depression

  2008cited by this paper
• Evolution of NMDA receptor cytoplasmic interaction domains: implications for organisation of synaptic signalling complexes

  2008cited by this paper
• Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

  2008influential reference
• NMDA Receptor Subunit NR2A Is Required for Rapidly Acquired Spatial Working Memory But Not Incremental Spatial Reference Memory

  2008cited by this paper
• Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and ‘schizophrenia-related’ behaviors

  2008cited by this paper
• An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder

  2008cited by this paper
• NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons

  2007cited by this paper
• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

  2007cited by this paper
• Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase

  2007cited by this paper
• NR2B Signaling Regulates the Development of Synaptic AMPA Receptor Current

  2007influential reference
• Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons.

  2006cited by this paper
• Relating NMDA Receptor Function to Receptor Subunit Composition: Limitations of the Pharmacological Approach

  2006influential reference
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• Genetic Inactivation of the NMDA Receptor NR2A Subunit has Anxiolytic- and Antidepressant-Like Effects in Mice

  2006influential reference
• Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

  2006cited by this paper
• Metabotropic Glutamate 5 Receptor Antagonism Is Associated with Antidepressant-Like Effects in Mice

  2006cited by this paper
• Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat

  2005cited by this paper
• Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs

  2004cited by this paper
• Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants

  2003cited by this paper
• Studies of NMDA Receptor Function and Stoichiometry with Truncated and Tandem Subunits

  2003influential reference
• 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition.

  2002cited by this paper
• Lower Sensitivity to Stress and Altered Monoaminergic Neuronal Function in Mice Lacking the NMDA Receptor ε4 Subunit

  2002cited by this paper
• Lower sensitivity to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor epsilon 4 subunit.

  2002cited by this paper
• Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit.

  2001cited by this paper
• Dysfunctions in Mice by NMDA Receptor Point Mutations NR1(N598Q) and NR1(N598R)

  2000cited by this paper
• Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo.

  1998cited by this paper
• Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice.

  1996influential reference
• Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit.

  1995cited by this paper
• The distribution of splice variants of the NMDAR1 subunit mRNA in adult rat brain.

  1995cited by this paper

• All roads lead to glutamate: NMDA and AMPA receptors as targets for rapid-acting antidepressants.

  2025cites this paper
• Glutamatergic Mechanisms Underlying the Antidepressant-Like Effects of 1-(Phenylselanyl)-2-(p-tolyl)indolizine in Mice.

  2025cites this paper
• Ketamine – A New Antidepressant Drug with Anti-Inflammatory Properties

  2023cites this paper
• Dysfunction of GluN3A subunit is involved in depression-like behaviors through synaptic deficits.

  2023cites this paper
• Ketamine as a Treatment Option for Severe Borderline Personality Disorder: A Case Report.

  2023cites this paper
• GluN2A mediates ketamine-induced rapid antidepressant-like responses

  2023cites this paper
• Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25‐6981, increases glutamate neurotransmission and induces antidepressant‐like effects

  2023cites this paper
• Antidepressant effects of repeated s-ketamine administration as NMDAR Antagonist: Involvement of CaMKIIα and mTOR signaling in the hippocampus of CUMS mice.

  2023cites this paper
• SAPAP3 regulates epileptic seizures involving GluN2A in post-synaptic densities

  2022cites this paper
• Region-Specific Enhancement of c-fos Expression by Combined Treatment With NMDA Receptor Agonists and Antagonists With Antidepressant Potential

  2022cites this paper
• The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: an emerging molecular "Lego" in the pathophysiology of psychiatric disorders. A systematic review and translational insight.

  2022cites this paper
• Ketamine in Psychiatric Disorders

  2021cites this paper
• Neuronal Nitric Oxide Synthase in Nucleus Accumbens Specifically Mediates Susceptibility to Social Defeat Stress through Cyclin-Dependent Kinase 5

  2021cites this paper
• Disease Modification in Epilepsy: Behavioural Accompaniments.

  2021cites this paper
• The receptor hypothesis and the pathogenesis of depression: genetic bases and biological correlates.

  2021cites this paper
• Targeting the dysfunction of glutamate receptors for the development of novel antidepressants.

  2021cites this paper
• The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver

  2021cites this paper
• Rislenemdaz treatment in the lateral habenula improves despair-like behavior in mice

  2020cites this paper
• 'That's the Esketamine, Baby, there's Nothing You Can Do about It!' An Update on Glutamatergic System in Suicidal Depression.

  2020cites this paper
• Rapastinel alleviates the neurotoxic effect induced by NMDA receptor blockade in the early postnatal mouse brain

  2020cites this paper
• Hydroxynorketamine Blocks N-Methyl-d-Aspartate Receptor Currents by Binding to Closed Receptors

  2020cites this paper
• Antidepressant effect of ketamine in chronic unpredictable mild stress model: Involvement of nod-like protein inflammasome driven pathway

  2019cites this paper
• MicroRNA-32-5p Knockout Eliminates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice Through Inhibition of Astrocyte Overactivity.

  2019cites this paper
• Prophylactic use of ketamine reduces postpartum depression in Chinese women undergoing cesarean section✰.

  2019cites this paper
• Neuroimmune signaling in alcohol use disorder

  2019cites this paper
• Adolescent Stress Disrupts the Maturation of Anxiety-related Behaviors and Alters the Developmental Trajectory of the Prefrontal Cortex in a Sex- and Age-specific Manner.

  2018cites this paper
• Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review

  2018cites this paper
• Ketamine – an antidepressant drug

  year unknowncites this paper